L'apport thérapeutique des approches protéomiques dans les cancers

Translated title of the contribution: The therapeutic contribution of proteomic approaches in cancers

B. Hamrita, H. B. Nasr, M. Kabbage, P. Hamann, L. Kuhn, C. Guillier, S. Remadi, A. Chaieb, H. Khairi, Lotfi Chouchane, K. Chahed

Research output: Contribution to journalArticle

Abstract

Up to now, there are no protein tumor markers with a specificity and sensitivity sufficient to have a utility in prognosis and early diagnosis of cancer. Recent advances in proteomics approaches have led to the identification of novel tumor markers of cancer that may have a utility in screening strategies and treatment. The purpose of the current review is to describe the major advances in cancer proteomics, especially those related to the study of serum biomarkers, immune-related responses (autoantibodies) and alterations in cellular proteins.

Original languageFrench
Pages (from-to)87-93
Number of pages7
JournalGynecologie Obstetrique Fertilite
Volume39
Issue number2
DOIs
Publication statusPublished - Feb 2011

Fingerprint

Tumor Biomarkers
Proteomics
Early Detection of Cancer
Autoantibodies
Immune Sera
Neoplasms
Proteins
Biomarkers
Sensitivity and Specificity
Therapeutics

Keywords

  • Proteomics
  • Therapeutic targets
  • Tumors markers
  • Two dimensional gel electrophoresis

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

Hamrita, B., Nasr, H. B., Kabbage, M., Hamann, P., Kuhn, L., Guillier, C., ... Chahed, K. (2011). L'apport thérapeutique des approches protéomiques dans les cancers. Gynecologie Obstetrique Fertilite, 39(2), 87-93. https://doi.org/10.1016/j.gyobfe.2010.12.005

L'apport thérapeutique des approches protéomiques dans les cancers. / Hamrita, B.; Nasr, H. B.; Kabbage, M.; Hamann, P.; Kuhn, L.; Guillier, C.; Remadi, S.; Chaieb, A.; Khairi, H.; Chouchane, Lotfi; Chahed, K.

In: Gynecologie Obstetrique Fertilite, Vol. 39, No. 2, 02.2011, p. 87-93.

Research output: Contribution to journalArticle

Hamrita, B, Nasr, HB, Kabbage, M, Hamann, P, Kuhn, L, Guillier, C, Remadi, S, Chaieb, A, Khairi, H, Chouchane, L & Chahed, K 2011, 'L'apport thérapeutique des approches protéomiques dans les cancers', Gynecologie Obstetrique Fertilite, vol. 39, no. 2, pp. 87-93. https://doi.org/10.1016/j.gyobfe.2010.12.005
Hamrita, B. ; Nasr, H. B. ; Kabbage, M. ; Hamann, P. ; Kuhn, L. ; Guillier, C. ; Remadi, S. ; Chaieb, A. ; Khairi, H. ; Chouchane, Lotfi ; Chahed, K. / L'apport thérapeutique des approches protéomiques dans les cancers. In: Gynecologie Obstetrique Fertilite. 2011 ; Vol. 39, No. 2. pp. 87-93.
@article{93210f8d60d54197993ddf9fa54d8fb5,
title = "L'apport th{\'e}rapeutique des approches prot{\'e}omiques dans les cancers",
abstract = "Up to now, there are no protein tumor markers with a specificity and sensitivity sufficient to have a utility in prognosis and early diagnosis of cancer. Recent advances in proteomics approaches have led to the identification of novel tumor markers of cancer that may have a utility in screening strategies and treatment. The purpose of the current review is to describe the major advances in cancer proteomics, especially those related to the study of serum biomarkers, immune-related responses (autoantibodies) and alterations in cellular proteins.",
keywords = "Proteomics, Therapeutic targets, Tumors markers, Two dimensional gel electrophoresis",
author = "B. Hamrita and Nasr, {H. B.} and M. Kabbage and P. Hamann and L. Kuhn and C. Guillier and S. Remadi and A. Chaieb and H. Khairi and Lotfi Chouchane and K. Chahed",
year = "2011",
month = "2",
doi = "10.1016/j.gyobfe.2010.12.005",
language = "French",
volume = "39",
pages = "87--93",
journal = "Gynecologie Obstetrique Fertilite et Senologie",
issn = "2468-7197",
publisher = "Elsevier Masson SAS",
number = "2",

}

TY - JOUR

T1 - L'apport thérapeutique des approches protéomiques dans les cancers

AU - Hamrita, B.

AU - Nasr, H. B.

AU - Kabbage, M.

AU - Hamann, P.

AU - Kuhn, L.

AU - Guillier, C.

AU - Remadi, S.

AU - Chaieb, A.

AU - Khairi, H.

AU - Chouchane, Lotfi

AU - Chahed, K.

PY - 2011/2

Y1 - 2011/2

N2 - Up to now, there are no protein tumor markers with a specificity and sensitivity sufficient to have a utility in prognosis and early diagnosis of cancer. Recent advances in proteomics approaches have led to the identification of novel tumor markers of cancer that may have a utility in screening strategies and treatment. The purpose of the current review is to describe the major advances in cancer proteomics, especially those related to the study of serum biomarkers, immune-related responses (autoantibodies) and alterations in cellular proteins.

AB - Up to now, there are no protein tumor markers with a specificity and sensitivity sufficient to have a utility in prognosis and early diagnosis of cancer. Recent advances in proteomics approaches have led to the identification of novel tumor markers of cancer that may have a utility in screening strategies and treatment. The purpose of the current review is to describe the major advances in cancer proteomics, especially those related to the study of serum biomarkers, immune-related responses (autoantibodies) and alterations in cellular proteins.

KW - Proteomics

KW - Therapeutic targets

KW - Tumors markers

KW - Two dimensional gel electrophoresis

UR - http://www.scopus.com/inward/record.url?scp=79952194615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952194615&partnerID=8YFLogxK

U2 - 10.1016/j.gyobfe.2010.12.005

DO - 10.1016/j.gyobfe.2010.12.005

M3 - Article

VL - 39

SP - 87

EP - 93

JO - Gynecologie Obstetrique Fertilite et Senologie

JF - Gynecologie Obstetrique Fertilite et Senologie

SN - 2468-7197

IS - 2

ER -